Elite Pharmaceuticals, Inc. Deferred Revenue, Revenue Recognized (Deprecated 2016-01-31)
Elite Pharmaceuticals, Inc. (ELTP) reported Deferred Revenue, Revenue Recognized (Deprecated 2016-01-31) of $10.00 thousand for the 9-month period ending 2013-12-31, per its 10-Q filed 2014-02-14.
Discontinued › Income Statement › Other Income
us-gaap:DeferredRevenueRevenueRecognized · last filed 2014-02-14
- Elite Pharmaceuticals, Inc. deferred revenue, revenue recognized (deprecated 2016-01-31) for the quarter ending 2013-06-30 was $3.33K.
- Elite Pharmaceuticals, Inc. deferred revenue, revenue recognized (deprecated 2016-01-31) for the quarter ending 2012-06-30 was -$3.34K.
| Period end | Deferred Revenue, Revenue Recognized (Deprecated 2016-01-31) 3 month | Deferred Revenue, Revenue Recognized (Deprecated 2016-01-31) 6 month | Deferred Revenue, Revenue Recognized (Deprecated 2016-01-31) 9 month |
|---|---|---|---|
| 2013-12-31 | $10.00K 10-Q · filed 2014-02-14 | ||
| 2013-09-30 | $6.67K 10-Q · filed 2013-11-14 | ||
| 2013-06-30 | $3.33K 10-Q · filed 2013-08-14 | ||
| 2012-12-31 | -$10.00K 10-Q · filed 2013-02-14 | ||
| 2012-09-30 | -$6.67K 10-Q · filed 2012-11-14 | ||
| 2012-06-30 | -$3.34K 10-Q · filed 2012-08-14 |